In this study, heterozygous GVs in ATM predisposed mainly to IDH-mutant astrocytoma at a median age of 36 years, compared to 58 years at primary glioma diagnosis in patients without GVs, mainly affected by glioblastoma. This evidence concerns the gene IDH1 and central nervous system cancer.